DE60221550D1 - Methode zur bestimmung der zellzyklusposition - Google Patents

Methode zur bestimmung der zellzyklusposition

Info

Publication number
DE60221550D1
DE60221550D1 DE60221550T DE60221550T DE60221550D1 DE 60221550 D1 DE60221550 D1 DE 60221550D1 DE 60221550 T DE60221550 T DE 60221550T DE 60221550 T DE60221550 T DE 60221550T DE 60221550 D1 DE60221550 D1 DE 60221550D1
Authority
DE
Germany
Prior art keywords
cell cycle
determining
provides
cycle position
constructs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221550T
Other languages
English (en)
Other versions
DE60221550T2 (de
Inventor
Jonathon Noe Pines
Cardiff Thomas
Anne Elizabeth Jones
Ian David Goodyer
Michael John Francis
Rahman Aziz Ismail
Jonathan Mark Kendall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Cancer Research Technology Ltd
Original Assignee
GE Healthcare UK Ltd
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare UK Ltd, Cancer Research Technology Ltd filed Critical GE Healthcare UK Ltd
Publication of DE60221550D1 publication Critical patent/DE60221550D1/de
Application granted granted Critical
Publication of DE60221550T2 publication Critical patent/DE60221550T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fuel Cell (AREA)
DE60221550T 2001-10-05 2002-09-12 Methode zur bestimmung der zellzyklusposition Expired - Lifetime DE60221550T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0123856.7A GB0123856D0 (en) 2001-10-05 2001-10-05 Method for determining cell cycle position
GB0123856 2001-10-05
PCT/GB2002/004258 WO2003031612A2 (en) 2001-10-05 2002-09-12 Method for determining cell cycle position

Publications (2)

Publication Number Publication Date
DE60221550D1 true DE60221550D1 (de) 2007-09-13
DE60221550T2 DE60221550T2 (de) 2008-04-17

Family

ID=9923245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221550T Expired - Lifetime DE60221550T2 (de) 2001-10-05 2002-09-12 Methode zur bestimmung der zellzyklusposition

Country Status (11)

Country Link
US (2) US7235401B2 (de)
EP (1) EP1432819B1 (de)
JP (1) JP4607454B2 (de)
AT (1) ATE368753T1 (de)
AU (1) AU2002326036B2 (de)
CA (1) CA2461133C (de)
DE (1) DE60221550T2 (de)
ES (1) ES2290326T3 (de)
GB (1) GB0123856D0 (de)
IL (1) IL160908A0 (de)
WO (1) WO2003031612A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7369696B2 (en) * 2003-04-02 2008-05-06 Ge Healthcare Uk Limited Classification of cells into subpopulations using cell classifying data
GB0307684D0 (en) * 2003-04-02 2003-05-07 Amersham Biosciences Uk Ltd Determining cell cycle phase data
EP1624748A4 (de) * 2003-05-08 2009-01-07 Health Research Inc Transgenes tiermodell für krebs- und stammzellen
US7745123B2 (en) 2004-07-23 2010-06-29 Ge Healthcare Uk Limited Cell cycle reporting cell line
US20070212707A1 (en) * 2004-07-23 2007-09-13 Ge Healthcare Uk Limited Cell cycle markers
CN101052645B (zh) * 2004-07-23 2012-10-10 通用电气医疗集团英国有限公司 细胞周期报道细胞系
JP5408839B2 (ja) * 2006-10-20 2014-02-05 オリンパス株式会社 細胞周期解析方法
EP2275567A1 (de) 2009-07-15 2011-01-19 Rheinische Friedrich-Wilhelms-Universität Bonn Nukleinsäureexpressionskonstrukt und dessen Verwendung als ein Zellproliferationsmarker
CA2839593A1 (en) 2011-07-15 2013-01-24 Sarepta Therapeutics, Inc. Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288641A (en) * 1984-06-04 1994-02-22 Arch Development Corporation Herpes Simplex virus as a vector
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
FR2658204A1 (fr) * 1990-02-12 1991-08-16 Inst Nat Sante Rech Med Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.
US6159691A (en) * 1996-05-15 2000-12-12 Prolifix Limited Assay for a putative regulator of cell cycle progression
US6124128A (en) * 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US6048693A (en) * 1996-10-16 2000-04-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
US6461813B2 (en) * 1998-09-21 2002-10-08 Rigel Pharmaceuticals, Inc. Multiparameter FACS assays to detect alterations in cell cycle regulation
DE19831420A1 (de) * 1998-07-14 2000-01-20 Hoechst Marion Roussel De Gmbh Expressionssysteme enthaltend chimäre Promotoren mit Bindungsstellen für rekombinante Transkriptionsfaktoren
US6764852B2 (en) * 1999-01-26 2004-07-20 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Internal ribosome entry site, vector containing same and uses thereof
GB0002261D0 (en) * 2000-02-02 2000-03-22 Amersham Pharm Biotech Uk Ltd Fluorescent detection method & reagent

Also Published As

Publication number Publication date
AU2002326036B2 (en) 2007-09-13
IL160908A0 (en) 2004-08-31
GB0123856D0 (en) 2001-11-28
US20040248133A1 (en) 2004-12-09
CA2461133C (en) 2009-02-10
ES2290326T3 (es) 2008-02-16
EP1432819A2 (de) 2004-06-30
EP1432819B1 (de) 2007-08-01
JP2005504550A (ja) 2005-02-17
WO2003031612A2 (en) 2003-04-17
JP4607454B2 (ja) 2011-01-05
WO2003031612A3 (en) 2003-10-30
CA2461133A1 (en) 2003-04-17
DE60221550T2 (de) 2008-04-17
US7235401B2 (en) 2007-06-26
US20070238123A1 (en) 2007-10-11
ATE368753T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
ATE540319T1 (de) Verfahren für die bestimmung von fk506
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
HUP0302803A2 (hu) Nukleinsavak izotermikus amplifikációja szilárd hordozón
DE60127469D1 (de) Potentiometrischer dna-mikroarray, verfahren zu dessen herstellung und verfahren zur nukleinsäureanalyse
ATE397752T1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
ATE393228T1 (de) Fusionsproteine und deren verwendung zur messung von protease-aktivität
ATE461292T1 (de) Erstellung von expressionsprofilen unter verwendung von mikroarrays
DE60315415D1 (de) Biosensor, magnetisches molekül messverfahren und messobjekt messverfahren
ATE480643T1 (de) Homogener nachweis von analyten
CY1107733T1 (el) Μεθοδος για τον χαρακτηρισμο μιας βιολογικης καταστασης χρησιμοποιωντας βαθμοnομημενα προφιλ γονιδιακης εκφρασης
DE60330842D1 (de) Für den nachweis von nukleinsäuren kompetente biologische rohderivate
ATE330038T1 (de) Nukleinsäure-biosensor
DK1399590T3 (da) Happier kortlægning
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DK1175511T3 (da) Fremgangsmåde og testsæt til opsamling og opbevaring af biologiske pröver
ATE241018T1 (de) Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden
SE0301951D0 (sv) New method
DE60221550D1 (de) Methode zur bestimmung der zellzyklusposition
CY1110543T1 (el) Προϊον και μεθοδος
ATE377753T1 (de) Nachweis von dna-bindungsproteinen
WO2005033330A3 (en) Fluorescent probes for use in protein kinase inhibitor binding assay
DE50211356D1 (de) Hybridverfahren zur herstellung von trägern für die analytbestimmung
DE60136746D1 (de) Oligonucleotide zur markierung von oligonukleotidsonden und proteine
DE69507017D1 (de) Cai-resistenzproteine kodierende dna, und ihre verwendung
DE60332076D1 (de) Doppelmessverfahren zur Anzeige des Inhalts von Poststücken

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1432819

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB